Search Results - "mRNA vaccine"

Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population by Silvia Sutandhio, Koichi Furukawa, Yukiya Kurahashi, Maria Istiqomah Marini, Gema Barlian Effendi, Natsumi Hasegawa, Hanako Ishimaru, Mitsuhiro Nishimura, Jun Arii, Yasuko Mori

Connect to this object online.

PP 1.37 - 00186 Investigating Short-Term Effects of COVID-19 mRNA Vaccination on Plasma Viremia and Intact HIV Reservoir Size in Individuals Receiving Antiretroviral Therapy (ART) by M.C. Duncan, F.H. Omondi, N.N. Kinloch, H.R. Lapointe, S. Speckmaier, N. Moran-Garcia, C.F. Lowe, M.G. Romney, T. Lawson, M. Harris, M.A. Brockman, Z.L. Brumme

Connect to this object online.

Neutralizing antibodies against SARS-CoV-2 in Brazilian pregnant women vaccinated with one or two doses of BNT162b2 mRNA vaccine (Pfizer/WyethTM) by Mauro César da Silva, Neila Caroline Henrique da Silva, Ana Laura Carneiro Gomes Ferreira, Fernanda Carneiro Gomes Ferreira, Maria Inês Bezerra de Melo, Letícia Micherlyne Xavier da Silva, Camila Rodrigues de Melo Barbosa, Jurandy Júnior Ferraz de Magalhães, George Tadeu Nunes Diniz, Ariani Impieri Souza, Norma Lucena-Silva

Connect to this object online.

Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines by Moe H. Kyaw, Julia Spinardi, Ling Zhang, Helen May Lin Oh, Amit Srivastava

Connect to this object online.

Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months by Salma Younes, Eleonora Nicolai, Duaa W. Al-Sadeq, Nadin Younes, Nader Al-Dewik, Haissam Abou-Saleh, Bushra Y. Abo-Halawa, Ali Hussein Eid, Massimo Pieri, Na Liu, Hanin I. Daas, Hadi M. Yassine, Parveen B. Nizamuddin, Laith J. Abu-Raddad, Gheyath K. Nasrallah

Connect to this object online.

The efficacy of SARS-CoV-2 antibody response after two dose mRNA vaccination in kidney and heart transplant recipients using a multiplex bead-based assay: Evaluating the factors affecting vaccine response by Steven J Forte, Angela J Toepp, Robert A Bray, David A Baran, Lauren T Gilgannon, Troy Williams, Shirui Chen, Hooman Sadr, Howard M Gebel, John M Herre, Thomas R McCune

Connect to this object online.

Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in JapanResearch in context by Yuta Yamaguchi, Shinichiro Nameki, Yasuhiro Kato, Ryotaro Saita, Tomoharu Sato, Sayaka Nagao, Teruaki Murakami, Yuko Yoshimine, Saori Amiya, Takayoshi Morita, Yasutaka Okita, Takahiro Kawasaki, Jun Fujimoto, Yasutaka Ueda, Yuichi Maeda, Akane Watanabe, Hyota Takamatsu, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Atsushi Kumanogoh

Connect to this object online.

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer ConsortiumResearch in context by Toni K. Choueiri, Chris Labaki, Ziad Bakouny, Chih-Yuan Hsu, Andrew L. Schmidt, Gilberto de Lima Lopes, Jr, Clara Hwang, Sunny R.K. Singh, Chinmay Jani, Lisa B. Weissmann, Elizabeth A. Griffiths, Susan Halabi, Ulysses Wu, Stephanie Berg, Timothy E. O'Connor, Trisha M. Wise-Draper, Orestis A. Panagiotou, Elizabeth J. Klein, Monika Joshi, Fares Yared, Miriam Santos Dutra, Na Tosha N. Gatson, Sibel Blau, Harpreet Singh, Rahul Nanchal, Rana R. McKay, Taylor K. Nonato, Ryann Quinn, Samuel M. Rubinstein, Matthew Puc, Blanche H. Mavromatis, Praveen Vikas, Bryan Faller, Howard A. Zaren, Salvatore Del Prete, Karen Russell, Daniel Y. Reuben, Melissa K. Accordino, Harpreet Singh, Christopher R. Friese, Sanjay Mishra, Donna R. Rivera, Yu Shyr, Dimitrios Farmakiotis, Jeremy L. Warner

Connect to this object online.

Kinetics of Anti-SARS-CoV-2 Antibody Response Following Two Doses of the BNT162b2 mRNA Vaccine: A Japanese Single-Center Primary Care Clinic Report Involving Volunteers and Patients with Autoimmune Disease by Tomoko Sugiura, Hiroaki Sugiura, Hiroaki Kato, Yuko Nariai, Yuuki Mizumoto, Kozue Hanada, Rieko Takahashi, Yukari Hinotubo, Naoko Tanaka, Mutsumi Sasaki, Haruki Eguchi, Hiroki Kamino, Takeshi Urano

Connect to this object online.

Safety and immunogenicity of primary vaccination with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: Two randomized, observer-blinded, placebo-controlled and dose-escalation phase 1 clinical trials by Gui-Ling Chen, Yuan-Zheng Qiu, Kai-Qi Wu, Ying Wu, Yuan-Hui Wang, Yu-Ying Zou, Cong-Gao Peng, Jie Zhao, Chang Su, Jun-Heng Ma, Shao-Nan Ni, Xing Wang, Ting-Han Jin, Qi Jiang, Tong Guo, Yan Xu, Chao-Chao Huang, Qing Zhang, Kai-Li Liu, Li Ji, Han-Yu Yang, Chun-Lei Li, Yu-Wen Su, Xiang Lu, Lan-Juan Li

Connect to this object online.

Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France by Tiffany Charmet, Laura Schaeffer, Rebecca Grant, Simon Galmiche, Olivia Chény, Cassandre Von Platen, Alexandra Maurizot, Alexandra Rogoff, Faïza Omar, Christophe David, Alexandra Septfons, Simon Cauchemez, Alexandre Gaymard, Bruno Lina, Louise H Lefrancois, Vincent Enouf, Sylvie van der Werf, Alexandra Mailles, Daniel Levy-Bruhl, Fabrice Carrat, Arnaud Fontanet

Connect to this object online.

Advances in DNA Vaccines

Subjects: “…mRNA vaccine…”
DOAB: download the publication
DOAB: description of the publication

Nanomaterials for Drug Delivery and Cancer Therapy

Subjects: “…mRNA vaccine…”
DOAB: download the publication
DOAB: description of the publication

Nanomaterials for Drug Delivery and Cancer Therapy

Subjects: “…mRNA vaccine…”
DOAB: download the publication
DOAB: description of the publication

Efficacy, Safety, and Immunogenicity of Vaccines against Viruses: From Network Medicine to Clinical Experimentation

Subjects: “…multi-epitope mRNA vaccine…”
DOAB: download the publication
DOAB: description of the publication

The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice by Zhiyin An, Yu Zhang, Xiang Yu, Jia Xia, Yanan Yin, Guoming Li, Jing Lu, Xuemei Fan, Yingjie Xu

Connect to this object online.

CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine by Li Q, Ren J, Liu W, Jiang G, Hu R

Connect to this object online.

Relative effectiveness of COVID-19 vaccine booster doses in people aged 65 and older-a retrospective cohort study in Türkiye by Mehmet Akif Sezerol, Alican Sarisaltik

Connect to this object online.

Optimization of the Linker Length of Mannose-Cholesterol Conjugates for Enhanced mRNA Delivery to Dendritic Cells by Liposomes by Fazhan Wang, Wen Xiao, Mostafa A. Elbahnasawy, Xingting Bao, Qian Zheng, Linhui Gong, Yang Zhou, Shuping Yang, Aiping Fang, Mohamed M. S. Farag, Jinhui Wu, Xiangrong Song

Connect to this object online.

Diagnosis of Angioimmunoblastic T Cell Lymphoma After Receiving First Dose of Pfizer/BioNTech (BNT162b2) Vaccine: A Case Report by Jai Kumar Khatri MD, Ihab Tahboub MD, Khurram Anwar MD, Moh'd Masoudi MD, Vincent Graffeo MD, Muhammad Omer Jamil MD

Connect to this object online.